v3.26.1
Note 4 - Equity Method Investment - Aggregate Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Net income (loss) attributable to common stockholders $ (5,479) $ (13,308) $ (12,467) $ 4,386
Lucid Diagnostics [Member]        
Revenue 1,474   2,730  
Net income (loss) attributable to common stockholders $ (14,715)   $ (38,343)